Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1236-1242.

• Liver Fibrosis and Cirrhosis • Previous Articles     Next Articles

The predictive value of lymphocyte-to-monocyte ratio in the prognosis of critically ill patients with liver cirrhosis based on the MIMIC database

Shen Wenjuan, Yang Li, Luo Liang   

  1. Department of Critical Care Medicine, the Seventh Affiliated Hospital of Sun Yat-sen University,Shenzhen 518107, China
  • Received:2025-09-30 Online:2026-09-30 Published:2026-11-16
  • Contact: Luo Liang,Email: luoliang@mail.sysu.edu.cn

Abstract: Objective To explore the impact and clinical significance of the lymphocyte-to-monocyte ratio (LMR) on 28-day mortality in cirrhotic patients in the ICU. Methods A retrospective analysis was conducted using data from 1,680 critically ill cirrhotic patients in the MIMIC-IV 2.0 database. Demographic information, clinical parameters, laboratory results, and clinical scores were collected. The LMR within 24 hours of ICU admission was calculated. All the patients were stratified into a low LMR group and a high LMR group based on the optimal cutoff value of LMR. The prognostic impact of LMR on 28-day mortality was assessed, and curve fitting analyses were performed to further explore the relationship between LMR and mortality. Results Among ICU patients with liver cirrhosis, the 28-day mortality rate was significantly higher in the low LMR group (LMR < 1.19) compared to that of the high LMR group (LMR ≥ 1.19) (39.2% vs. 23.1%). The incidence of sepsis and acute kidney injury (AKI) was also significantly higher in the low LMR group than that in the high LMR group (82.5% vs. 70.7% for sepsis; 77.2% vs. 65.4% for AKI). The survivors had higher LMR levels than non-survivors (2.68 vs. 2.12; P<0.001). By multivariate logistic regression analysis, after adjusting for potential confounders including sex, age, total bilirubin, albumin, creatinine, INR, and CCI score, it was showed that LMR ≥ 1.19 was associated with reduced 28-day mortality [OR (95% CI): 0.69 (0.52~0.92), P=0.01] when compared with LMR < 1.19. When grouped by tertiles, both the LMR 1.27~2.50 group and the LMR > 2.50 group were associated with decreased ICU mortality in cirrhotic patients [OR (95% CI) = 0.71 (0.56~0.89) and 0.70 (0.54~0.90)]. Conclusion The lymphocyte-to-monocyte ratio (LMR) is an independent predictor for 28-day mortality in critically ill patients with liver cirrhosis. Furthermore, a dose-response relationship was shown between LMR levels and the mortality risks, indicating a significant application value of LMR level in the risk stratification and decision-making intervention.

Key words: Lymphocyte-to-monocyte ratio, Critical illness, Liver cirrhosis, Inflammatory marker, Prognosis